Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
24-Nov-2025 | 283.85 | 283.85 | 270.1 | 271.55 | 4,135 | 4,33,91,011.35 | 77,744 |
25-Nov-2025 | 271.55 | 275.75 | 270.75 | 273.55 | 2,592 | 1,87,24,413.3 | 29,659 |
26-Nov-2025 | 277.7 | 327 | 276.5 | 322.3 | 1,51,641 | 3,71,33,18,889.6 | 11,45,669 |
27-Nov-2025 | 327.35 | 335 | 311.4 | 319.6 | 71,852 | 1,58,32,85,932.8 | 4,58,940 |
28-Nov-2025 | 319.55 | 325.75 | 311.6 | 319.2 | 15,521 | 45,67,91,974.35 | 2,00,587 |
01-Dec-2025 | 323.55 | 325.55 | 311.2 | 314.05 | 8,866 | 22,85,11,765.45 | 1,44,177 |
02-Dec-2025 | 314 | 314.5 | 308.15 | 311.5 | 3,652 | 7,33,16,539.1 | 73,897 |
03-Dec-2025 | 310.55 | 323.5 | 303.6 | 320.05 | 16,789 | 30,74,06,285.7 | 2,60,174 |
04-Dec-2025 | 323 | 329.5 | 315.65 | 322.45 | 16,081 | 25,75,19,424.85 | 2,16,760 |
05-Dec-2025 | 321.1 | 321.7 | 312.25 | 317 | 8,752 | 11,56,14,302.15 | 1,01,702 |
08-Dec-2025 | 317 | 326.65 | 310.1 | 319.85 | 12,811 | 18,77,78,241.2 | 1,65,407 |
09-Dec-2025 | 318.95 | 330 | 312 | 326.6 | 9,766 | 14,13,81,162.05 | 1,94,900 |
10-Dec-2025 | 330.1 | 334 | 307.75 | 310.8 | 19,282 | 31,37,98,126.15 | 3,24,955 |
11-Dec-2025 | 312.8 | 322 | 306.4 | 320.9 | 11,411 | 16,01,03,535.55 | 1,25,719 |
12-Dec-2025 | 320.9 | 322.95 | 314.5 | 320.7 | 6,165 | 8,00,09,771.8 | 93,445 |
15-Dec-2025 | 325 | 328 | 320.7 | 323.95 | 9,394 | 14,87,30,383.15 | 1,43,243 |
16-Dec-2025 | 325.4 | 325.4 | 315 | 316.15 | 4,308 | 7,06,04,555.3 | 98,698 |
17-Dec-2025 | 317 | 317.7 | 304.2 | 310.05 | 5,863 | 8,56,16,200.95 | 80,327 |
18-Dec-2025 | 310.1 | 310.8 | 302.1 | 303.75 | 4,649 | 6,47,35,317.35 | 81,689 |
19-Dec-2025 | 304.8 | 314 | 304.15 | 311.3 | 5,994 | 7,49,78,479.65 | 65,693 |
22-Dec-2025 | 311.75 | 316.55 | 311.75 | 313.7 | 3,217 | 3,94,53,588.1 | 47,814 |
23-Dec-2025 | 316 | 316.65 | 310.05 | 315.25 | 4,440 | 5,14,00,717.95 | 70,317 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
